Lorlatinib in a Child with <i>ALK</i> -Fusion–Positive High-Grade Glioma
Aditi Bagchi, Brent A. Orr, Olivia Campagne, Sandeep Kumar Dhanda, Sreenath Nair, Quynh T. Tran, Anthony M. Christensen, Amar Gajjar, Larissa V. Furtado, Aksana Vasilyeva, Frederick A. Boop, Clinton F. Stewart, Giles Robinson
Abstract
Lorlatinib Response in ALK-Fusion–Positive Glioma A child near death with an ALK-fusion–positive high-grade glioma refractory to standard treatment had a dramatic response when treatment with lorla...
Topics & Concepts
GliomaRefractory (planetary science)FusionMedicineCancer researchInternal medicineBiologyPhilosophyAstrobiologyLinguisticsGlioma Diagnosis and TreatmentCancer therapeutics and mechanismsHepatocellular Carcinoma Treatment and Prognosis